|Articles|September 22, 2021
Quality control in binding studies
Author(s)Wyatt Technology
Screening studies of candidate proteins are critical in biopharmaceutical discovery. Preliminary assessment of the quality of the protein solutions by dynamic light scattering is imperative for reliable binding results.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
5